ATHA Stock Price

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline inclu...

June 28, 2022
8:12 AM

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Barbara Kollmeyer
marketwatch.com

News category

Other finance news in Bothell

8
June
Finance newsFinance news
Bothell
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference Continue reading →
2
December
Finance newsFinance news
Bothell
Lyell Immunopharma to Participate in BofA Securities Biotech Conference Continue reading →
6
July
Finance newsFinance news
Bothell
"VAPR" E-Cite Motors Reduces OS by 10,000,000 Shares by Buying Back 5,000,000 Shares for Cash and CEO Returns 5,000,000 Shares to Facilitate the Transaction Continue reading →
28
June
Finance newsFinance news
Bothell
ATHA Stock Price Continue reading →
28
June
Finance newsFinance news
Bothell
Sumitomo Forestry : Four Japanese Companies Jointly Commence on Multifamily Development Project in the Suburbs of Seattle~Providing a living environment with both convenience and recreation~ Continue reading →